BRAZE INC-A (BRZE) Fundamental Analysis & Valuation

NASDAQ:BRZE • US10576N1028

Current stock price

18.77 USD
+0.19 (+1.02%)
At close:
19.136 USD
+0.37 (+1.95%)
Pre-Market:

This BRZE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. BRZE Profitability Analysis

1.1 Basic Checks

  • BRZE had positive earnings in the past year.
  • BRZE had a positive operating cash flow in the past year.
  • BRZE had negative earnings in each of the past 5 years.
  • In multiple years BRZE reported negative operating cash flow during the last 5 years.
BRZE Yearly Net Income VS EBIT VS OCF VS FCFBRZE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

  • With a Return On Assets value of -11.22%, BRZE is not doing good in the industry: 63.54% of the companies in the same industry are doing better.
  • BRZE has a Return On Equity (-19.41%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -11.22%
ROE -19.41%
ROIC N/A
ROA(3y)-15.85%
ROA(5y)-15.52%
ROE(3y)-27.38%
ROE(5y)-29.17%
ROIC(3y)N/A
ROIC(5y)N/A
BRZE Yearly ROA, ROE, ROICBRZE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -10 -20 -30 -40

1.3 Margins

  • BRZE has a Gross Margin (68.13%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of BRZE has grown nicely.
  • The Profit Margin and Operating Margin are not available for BRZE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.04%
GM growth 5Y1.88%
BRZE Yearly Profit, Operating, Gross MarginsBRZE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. BRZE Health Analysis

2.1 Basic Checks

  • BRZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BRZE has more shares outstanding
  • Compared to 5 years ago, BRZE has more shares outstanding
  • BRZE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BRZE Yearly Shares OutstandingBRZE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
BRZE Yearly Total Debt VS Total AssetsBRZE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 2.39 indicates that BRZE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • BRZE has a Altman-Z score of 2.39. This is in the better half of the industry: BRZE outperforms 60.65% of its industry peers.
  • BRZE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.39
ROIC/WACCN/A
WACC10.82%
BRZE Yearly LT Debt VS Equity VS FCFBRZE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 1.36 indicates that BRZE should not have too much problems paying its short term obligations.
  • BRZE has a Current ratio (1.36) which is in line with its industry peers.
  • BRZE has a Quick Ratio of 1.36. This is a normal value and indicates that BRZE is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of BRZE (1.36) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.36
BRZE Yearly Current Assets VS Current LiabilitesBRZE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. BRZE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 1900.00% over the past year.
  • Looking at the last year, BRZE shows a very strong growth in Revenue. The Revenue has grown by 22.95%.
  • Measured over the past years, BRZE shows a very strong growth in Revenue. The Revenue has been growing by 43.83% on average per year.
EPS 1Y (TTM)1900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)22.95%
Revenue growth 3Y35.6%
Revenue growth 5Y43.83%
Sales Q2Q%25.51%

3.2 Future

  • Based on estimates for the next years, BRZE will show a very strong growth in Earnings Per Share. The EPS will grow by 59.65% on average per year.
  • Based on estimates for the next years, BRZE will show a quite strong growth in Revenue. The Revenue will grow by 18.00% on average per year.
EPS Next Y138.75%
EPS Next 2Y89.37%
EPS Next 3Y77.12%
EPS Next 5Y59.65%
Revenue Next Year24.2%
Revenue Next 2Y20.71%
Revenue Next 3Y19.31%
Revenue Next 5Y18%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BRZE Yearly Revenue VS EstimatesBRZE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
BRZE Yearly EPS VS EstimatesBRZE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. BRZE Valuation Analysis

4.1 Price/Earnings Ratio

  • BRZE is valuated quite expensively with a Price/Earnings ratio of 46.92.
  • Compared to the rest of the industry, the Price/Earnings ratio of BRZE is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 25.71, BRZE is valued quite expensively.
  • Based on the Price/Forward Earnings ratio of 29.08, the valuation of BRZE can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BRZE is on the same level as its industry peers.
  • BRZE's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.83.
Industry RankSector Rank
PE 46.93
Fwd PE 29.08
BRZE Price Earnings VS Forward Price EarningsBRZE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • BRZE's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 35.62
EV/EBITDA N/A
BRZE Per share dataBRZE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BRZE's earnings are expected to grow with 77.12% in the coming years.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y89.37%
EPS Next 3Y77.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BRZE Dividend Analysis

5.1 Amount

  • No dividends for BRZE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BRZE Fundamentals: All Metrics, Ratios and Statistics

BRAZE INC-A

NASDAQ:BRZE (3/13/2026, 8:12:40 PM)

Premarket: 19.136 +0.37 (+1.95%)

18.77

+0.19 (+1.02%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-09
Earnings (Next)03-24
Inst Owners75.39%
Inst Owner Change7.96%
Ins Owners10.11%
Ins Owner Change43.69%
Market Cap2.12B
Revenue(TTM)693.41M
Net Income(TTM)-116.88M
Analysts85.19
Price Target43.75 (133.08%)
Short Float %12.03%
Short Ratio3.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)192.95%
Min EPS beat(2)-5.12%
Max EPS beat(2)391.01%
EPS beat(4)3
Avg EPS beat(4)140.47%
Min EPS beat(4)-5.12%
Max EPS beat(4)391.01%
EPS beat(8)7
Avg EPS beat(8)191.16%
EPS beat(12)11
Avg EPS beat(12)143.38%
EPS beat(16)15
Avg EPS beat(16)112.23%
Revenue beat(2)2
Avg Revenue beat(2)2.72%
Min Revenue beat(2)1.64%
Max Revenue beat(2)3.8%
Revenue beat(4)4
Avg Revenue beat(4)1.64%
Min Revenue beat(4)0.14%
Max Revenue beat(4)3.8%
Revenue beat(8)8
Avg Revenue beat(8)1.47%
Revenue beat(12)12
Avg Revenue beat(12)1.76%
Revenue beat(16)16
Avg Revenue beat(16)2.28%
PT rev (1m)-5.1%
PT rev (3m)-4.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.15%
EPS NY rev (1m)0%
EPS NY rev (3m)2.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.9%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.88%
Valuation
Industry RankSector Rank
PE 46.93
Fwd PE 29.08
P/S 3.05
P/FCF 35.62
P/OCF 30.59
P/B 3.51
P/tB 7.82
EV/EBITDA N/A
EPS(TTM)0.4
EY2.13%
EPS(NY)0.65
Fwd EY3.44%
FCF(TTM)0.53
FCFY2.81%
OCF(TTM)0.61
OCFY3.27%
SpS6.15
BVpS5.34
TBVpS2.4
PEG (NY)0.34
PEG (5Y)N/A
Graham Number6.93
Profitability
Industry RankSector Rank
ROA -11.22%
ROE -19.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.13%
FCFM 8.56%
ROA(3y)-15.85%
ROA(5y)-15.52%
ROE(3y)-27.38%
ROE(5y)-29.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.04%
GM growth 5Y1.88%
F-Score4
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 60.58%
Cap/Sales 1.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.36
Altman-Z 2.39
F-Score4
WACC10.82%
ROIC/WACCN/A
Cap/Depr(3y)240.58%
Cap/Depr(5y)230.69%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y138.75%
EPS Next 2Y89.37%
EPS Next 3Y77.12%
EPS Next 5Y59.65%
Revenue 1Y (TTM)22.95%
Revenue growth 3Y35.6%
Revenue growth 5Y43.83%
Sales Q2Q%25.51%
Revenue Next Year24.2%
Revenue Next 2Y20.71%
Revenue Next 3Y19.31%
Revenue Next 5Y18%
EBIT growth 1Y4.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year816.66%
EBIT Next 3Y189.22%
EBIT Next 5Y124.87%
FCF growth 1Y1317.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2175.29%
OCF growth 3YN/A
OCF growth 5YN/A

BRAZE INC-A / BRZE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BRAZE INC-A?

ChartMill assigns a fundamental rating of 4 / 10 to BRZE.


Can you provide the valuation status for BRAZE INC-A?

ChartMill assigns a valuation rating of 4 / 10 to BRAZE INC-A (BRZE). This can be considered as Fairly Valued.


How profitable is BRAZE INC-A (BRZE) stock?

BRAZE INC-A (BRZE) has a profitability rating of 2 / 10.


What is the earnings growth outlook for BRAZE INC-A?

The Earnings per Share (EPS) of BRAZE INC-A (BRZE) is expected to grow by 138.75% in the next year.